wogonin and Brain-Ischemia

wogonin has been researched along with Brain-Ischemia* in 3 studies

Other Studies

3 other study(ies) available for wogonin and Brain-Ischemia

ArticleYear
Wogonin inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion.
    Biological & pharmaceutical bulletin, 2004, Volume: 27, Issue:10

    The present study evaluated the effect of wogonin, a flavonoid originated from the root of Scutellaria baicalensis GEORGI, on focal ischemic brain injury in rats. Focal brain ischemia was induced by the permanent occlusion of middle cerebral artery (pMCAO) for 24 h with a silicone rubber cylinder inserted through the right internal carotid artery. We found that wogonin, intraperitoneally administered at a dosage of 20 mg/kg at 30 min before and 4 h after the surgery, reduced the pMCAO-induced infarct areas in the cerebral cortex as well as in the striatum. The total volume of infarction was significantly reduced by the treatment with wogonin. In addition, wogonin was found to significantly improve the pMCAO-induced behavioral deficits at 24 h after the surgery. Taken together, these results demonstrate that wogonin inhibits ischemic brain injury and improves behavioral dysfunction caused by pMCAO. These findings, along with previous reports demonstrating the neuroprotective effects of wogonin, provide strong pharmacological basis for the use of wogonin or Scutellaria baicalensis in the treatment of stroke.

    Topics: Animals; Arterial Occlusive Diseases; Behavior, Animal; Brain Infarction; Brain Ischemia; Cerebral Cortex; Corpus Striatum; Disease Models, Animal; Flavanones; Male; Middle Cerebral Artery; Neuroprotective Agents; Phytotherapy; Plant Roots; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis

2004
Neuroprotective effect of wogonin: potential roles of inflammatory cytokines.
    Archives of pharmacal research, 2004, Volume: 27, Issue:9

    Wogonin (5,7-dihydroxy-8-methoxyflavone), an active component originated from the root of Scutellaria baicalensis Georgi, has been reported to possess antioxidant and anti-inflammatory properties. In this study, we investigated the neuroprotective effect of wogonin in a focal cerebral ischemia rat model. Wogonin markedly reduced the infarct volume after 2 h middle cerebral artery occlusion followed by 22 h reperfusion. Wogonin decreased the production of nitric oxide and inflammatory cytokines such as TNF-alpha and IL-6 in lipopolisaccharide-stimulated microglial cells. While wogonin reduced the activity of NF-kappaB, it did not change the activity of mitogen-activated protein kinases family members, p38, ERK and JNK. The lipopolisaccharide-stimulated production of NO and cytokines was significantly blocked by various kinds of NF-kappaB inhibitors such as N-acetyl cysteine, pyrrolidinedithiocarbamate and MG-132. The data may indicate that wogonin has neuroprotective effect by preventing the overactivation of microglial cells, possibly by inactivating NF-kappaB signaling pathway.

    Topics: Animals; Brain Ischemia; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Flavanones; Inflammation Mediators; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley

2004
Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death.
    Brain research, 2003, Oct-03, Volume: 986, Issue:1-2

    Neuronal injury in the central nervous system following ischemic insult is believed to result from glutamate toxicity and glucose deprivation. In this study, polyphenols isolated from Scutellaria baicalensis Georgi, including baicalin, baicalein, and wogonin, were investigated for their neuroprotective effects against glutamate/NMDA (Glu/NMDA) stimulation and glucose deprivation in primary cultured rat brain neurons. Cell death was accessed by lactate dehydrogenase (LDH) release assay for necrosis, and mitochondrial activity was accessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reduction activity assay. It was found that both baicalin and baicalein decreased LDH release of the cultured neurons after 24 h treatment, whereas wogonin profoundly increased LDH release after 2 h treatment and resulted in neuronal death after 24 h. Glu/NMDA treatment profoundly increased LDH release and moderately decreased MTT reduction activity in an NMDA receptor-dependent manner. Both baicalin and baicalein significantly reduced Glu/NMDA-increased LDH release, in which baicalein is much more potent than baicalin. Glu/NMDA-increased intracellular calcium was also significantly attenuated by baicalin and baicalein. Baicalin and baicalein did not affect glutamate receptor binding activity, but baicalein did moderately decrease Glu/NMDA-induced nitric oxide (NO) production. In the glucose deprivation (GD) study, baicalein but not baicalin showed significant protective effects on the GD-increased LDH release, without affecting the GD-induced NO production, in cultured rat brain neurons. These results suggest that baicalein is the most effective compound among three polyphenols tested in preventing neurotoxicity induced by both glutamate and GD, whereas baicalin was only effective in preventing glutamate toxicity. Wogonin might have a neurotoxic effect on the brain.

    Topics: Animals; Brain Ischemia; Calcium Signaling; Cell Survival; Cells, Cultured; Central Nervous System; Drugs, Chinese Herbal; Excitatory Amino Acid Agonists; Female; Flavanones; Flavonoids; Glucose; Glutamic Acid; L-Lactate Dehydrogenase; Mitochondria; Nerve Degeneration; Neurons; Neuroprotective Agents; Nitric Oxide; Phenols; Polyphenols; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Scutellaria baicalensis

2003